[go: up one dir, main page]

DK595187D0 - Minactivin og fremgangsmaade til fremstilling deraf - Google Patents

Minactivin og fremgangsmaade til fremstilling deraf

Info

Publication number
DK595187D0
DK595187D0 DK595187A DK595187A DK595187D0 DK 595187 D0 DK595187 D0 DK 595187D0 DK 595187 A DK595187 A DK 595187A DK 595187 A DK595187 A DK 595187A DK 595187 D0 DK595187 D0 DK 595187D0
Authority
DK
Denmark
Prior art keywords
minactivin
purification
biologically active
relates
producing
Prior art date
Application number
DK595187A
Other languages
English (en)
Other versions
DK595187A (da
DK172400B1 (da
Inventor
Toni Marie Antalis
Michael Thomas Barnes
Michelle Alison Clarke
Peter Leonard Devine
Neil Howard Goss
Philip Ralph Lehrbach
Original Assignee
Biotech Australia Pty Ltd
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd, Univ Australian filed Critical Biotech Australia Pty Ltd
Publication of DK595187D0 publication Critical patent/DK595187D0/da
Publication of DK595187A publication Critical patent/DK595187A/da
Application granted granted Critical
Publication of DK172400B1 publication Critical patent/DK172400B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8132—Plasminogen activator inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9723—Urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
DK595187A 1986-03-13 1987-11-13 Fremgangsmåde til fremstilling af renset minactivin, minactivinkodende DNA-molekyle, rekombinant DNA-molekyle, sammensmeltet gen, vært, reagent til lokalisering og definering af grænserne for tumorer i histologiske prøver, samt anvendelse af det rekombinante DNA-molekyle, minactivinet og peptider deraf DK172400B1 (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
AUPH501786 1986-03-13
AUPH501786 1986-03-13
AUPH603386 1986-05-22
AUPH603386 1986-05-22
AUPH810086 1986-09-18
AUPH810086 1986-09-18
AUPH910486 1986-11-21
AUPH910486 1986-11-21
PCT/AU1987/000068 WO1987005628A1 (en) 1986-03-13 1987-03-13 Minactivin produced by recombinant dna technology
AU8700068 1987-03-13

Publications (3)

Publication Number Publication Date
DK595187D0 true DK595187D0 (da) 1987-11-13
DK595187A DK595187A (da) 1988-07-21
DK172400B1 DK172400B1 (da) 1998-05-18

Family

ID=27424177

Family Applications (2)

Application Number Title Priority Date Filing Date
DK595187A DK172400B1 (da) 1986-03-13 1987-11-13 Fremgangsmåde til fremstilling af renset minactivin, minactivinkodende DNA-molekyle, rekombinant DNA-molekyle, sammensmeltet gen, vært, reagent til lokalisering og definering af grænserne for tumorer i histologiske prøver, samt anvendelse af det rekombinante DNA-molekyle, minactivinet og peptider deraf
DK027097A DK27097A (da) 1986-03-13 1997-03-13 Minactivin og fremgangsmåde til fremstilling deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK027097A DK27097A (da) 1986-03-13 1997-03-13 Minactivin og fremgangsmåde til fremstilling deraf

Country Status (13)

Country Link
US (1) US5426044A (da)
EP (1) EP0238275B1 (da)
JP (2) JP2589996B2 (da)
KR (1) KR960001820B1 (da)
CN (2) CN1032019C (da)
AT (1) ATE132192T1 (da)
CA (1) CA1338381C (da)
DE (1) DE3751646T2 (da)
DK (2) DK172400B1 (da)
IL (1) IL81879A (da)
NO (1) NO178504C (da)
NZ (1) NZ219608A (da)
WO (1) WO1987005628A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
ES2104610T3 (es) * 1989-09-05 1997-10-16 Biotech Australia Pty Ltd Proceso para la preparacion de pai-2.
AU625018B2 (en) * 1989-12-20 1992-06-25 Biotech Australia Pty Limited Variants of pai-2
GB9026737D0 (en) * 1990-12-08 1991-01-30 Delta Biotechnology Ltd Cancer treatment
US5994309A (en) 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
CN102586187A (zh) * 2012-02-23 2012-07-18 深圳市中美康士生物科技有限公司 一种中性粒细胞体外保存方法及培养基

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
EP0192671B1 (en) * 1984-08-13 1993-12-29 Biotechnology Australia Pty. Ltd. Minactivin
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation

Also Published As

Publication number Publication date
EP0238275A3 (en) 1989-05-10
JP2660681B2 (ja) 1997-10-08
DK595187A (da) 1988-07-21
JPH08112094A (ja) 1996-05-07
NO178504B (no) 1996-01-02
ATE132192T1 (de) 1996-01-15
CN1032019C (zh) 1996-06-12
NZ219608A (en) 1991-05-28
KR880701073A (ko) 1988-07-25
WO1987005628A1 (en) 1987-09-24
CA1338381C (en) 1996-06-11
NO178504C (no) 1996-04-10
IL81879A (en) 1994-07-31
JP2589996B2 (ja) 1997-03-12
JPS63503354A (ja) 1988-12-08
CN87102725A (zh) 1987-11-11
EP0238275A2 (en) 1987-09-23
DK172400B1 (da) 1998-05-18
EP0238275B1 (en) 1995-12-27
US5426044A (en) 1995-06-20
DK27097A (da) 1997-03-13
NO874704L (no) 1987-11-11
CN1100957A (zh) 1995-04-05
NO874704D0 (no) 1987-11-11
KR960001820B1 (ko) 1996-02-05
DE3751646T2 (de) 1996-10-17
DE3751646D1 (de) 1996-02-08

Similar Documents

Publication Publication Date Title
FI100056B (fi) Ihmisproapolipoproteiinin A-I ilmaiseminen
ATE386800T1 (de) Immunogene chimäre umfassend nucleinsäuresequenzen, die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
EP0174367A4 (en) HOSTS AND METHODS FOR PRODUCING RECOMBINANT PRODUCTS IN LARGE QUANTITIES.
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
FI99116B (fi) Menetelmä valmistaa hevosen -interferonia
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ATE338113T1 (de) Transferrin-rezeptor gene von haemophilus
ATE134219T1 (de) Menschliches mk gen und protein-sequenz
EP0192175A3 (de) Polypeptide des Rhinovirusstammes HRV2 sowie die hierfür codierenden DNA-Moleküle
NO930428D0 (no) Proteinstrukturen til plantetoksingelonin
DK595187D0 (da) Minactivin og fremgangsmaade til fremstilling deraf
ES2009588A6 (es) Un metodo para la preparacion de un polipeptido.
DK0652903T3 (da) Nyt humant rekombinant gammainterferon
EP0261403A3 (de) Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle
DK210288D0 (da) Overproduktion af exocelllulaere proteiner
DE602004019556D1 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon

Legal Events

Date Code Title Description
ATS Application withdrawn
AHS Application shelved for other reasons than non-payment
AHS Application shelved for other reasons than non-payment
AHS Application shelved for other reasons than non-payment
AHS Application shelved for other reasons than non-payment
AHS Application shelved for other reasons than non-payment
AHB Application shelved due to non-payment
AGE Re-establishment of rights: approved
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK